|
SKIV2L2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.53600004832089E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.75210004680093E-09 |
| Normal-vs-Stage2 |
1.507530E-02 |
| Normal-vs-Stage3 |
7.382600E-03 |
| Normal-vs-Stage4 |
2.719900E-02 |
| Stage1-vs-Stage2 |
3.576600E-01 |
| Stage1-vs-Stage3 |
3.977600E-01 |
| Stage1-vs-Stage4 |
7.575200E-01 |
| Stage2-vs-Stage3 |
8.765800E-01 |
| Stage2-vs-Stage4 |
7.002400E-01 |
| Stage3-vs-Stage4 |
8.135200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.55410004257328E-09 |
| Normal-vs-AfricanAmerican |
8.33399999999873E-05 |
| Normal-vs-Asian |
2.890400E-01 |
| Caucasian-vs-AfricanAmerican |
4.962200E-01 |
| Caucasian-vs-Asian |
5.067000E-01 |
| AfricanAmerican-vs-Asian |
6.541000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.97329930173851E-11 |
| Normal-vs-Female |
6.731800E-02 |
| Male-vs-Female |
7.66360000000743E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.45730000003608E-06 |
| Normal-vs-Extreme_Weight |
1.36009999929243E-08 |
| Normal-vs-Obese |
2.766700E-04 |
| Normal-vs-Extreme_Obese |
6.556700E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.705000E-01 |
| Normal_Weight-vs-Obese |
2.183600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.929000E-01 |
| Extreme_Weight-vs-Obese |
1.186210E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.739600E-01 |
| Obese-vs-Extreme_Obese |
2.713600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.475800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.41690000000383E-05 |
| Normal-vs-Age(61-80Yrs) |
2.2099000407394E-10 |
| Normal-vs-Age(81-100Yrs) |
2.737300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.809200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.685200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.055200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.784100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.293200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.706800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.35349559022325E-11 |
| Normal-VS-Type2 PRCC |
1.955650E-04 |
| Normal-VS-KIRP CIMP |
1.60841999999883E-05 |
| Normal-VS-Unclassified PRCC |
1.043990E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.543600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.537800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.834300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.634980E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.350800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.074200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.91050000001248E-07 |
| Normal-vs-N1 |
1.165840E-01 |
| Normal-vs-N2 |
1.977830E-03 |
| N0-vs-N1 |
4.730300E-02 |
| N0-vs-N2 |
9.173000E-01 |
| N1-vs-N2 |
3.091200E-01 |
|
|
